/Companies

Eleven P15

Denver, US · Founded 2016 · Delaware corporation

Find your way into Eleven P15

Sign up to see every warm intro you have to Eleven P15

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Eleven P15 team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Eleven P15 is a company focused on the genetics of pulmonary fibrosis, with work spanning biomarker development, genomics, and animal models of human disease.

Founders & leadership

Eleven P15 was founded in 2016 by David Schwartz.

DS
David SchwartzCSO
BS
Bruce SchroffelNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.6M disclosed across 1 round · 2019

▶$1.6MraisedNov 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bruce SchroffelExecutive Officer
  • David SchwartzExecutive Officer, Director, Promoter
Offering amount
$1.6M
Amount sold
$1.6M
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Eleven P15 do?
Eleven P15 is a company focused on the genetics of pulmonary fibrosis, with work spanning biomarker development, genomics, and animal models of human disease.
Who founded Eleven P15?
Eleven P15 was founded by David Schwartz in 2016.
How much funding has Eleven P15 raised?
Eleven P15 has disclosed $1.6M raised across 1 round.
Where is Eleven P15 headquartered?
Eleven P15 is headquartered in Denver, US.